Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)-Reference-Cited by-同舟云学术

Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)

Published:2023-09 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Colombel Jean-Frederic^ORCID,Ungaro Ryan C.,Sands Bruce E.,Siegel Corey A.,Wolf Douglas C.,Valentine John F.,Feagan Brian G.,Neustifter Blue,Kadali Harisha,Nazarey Pradeep,James Alexandra,Jairath Vipul,Qasim Khan Rana M.

Funder

National Institutes of Health

Takeda Pharmaceuticals USA Inc

Takeda Pharmaceutical Company

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference53 articles.

1. Crohn's disease;Torres;Lancet,2017

2. Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort;Thia;Gastroenterology,2010

3. Preventing collateral damage in Crohn's disease: the Lémann Index;Fiorino;J Crohns Colitis,2016

4. Crohn's disease;Roda;Nat Rev Dis Primers,2020

5. AGA clinical practice guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease;Feuerstein;Gastroenterology,2021

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Advanced Targeted Therapy in Inflammatory Bowel Diseases: An Extensive Update;Inflammatory Bowel Diseases;2024-08-29

2. Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?;Gut;2024-07-17

3. When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease;American Journal of Gastroenterology;2024-07-15

4. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease;World Journal of Gastroenterology;2024-07-07

5. The Future of Clinical Trials in Inflammatory Bowel Disease;Clinical Gastroenterology and Hepatology;2024-07